Literature DB >> 23307985

Modern staging of small cell lung cancer.

Gregory P Kalemkerian1, Shirish M Gadgeel.   

Abstract

For many years, small cell lung cancer (SCLC) has been staged using the Veterans Affairs classification system, which includes only 2 stages: limited (primary tumor and regional lymph nodes within a tolerable radiation field) and extensive (anything beyond limited stage). The TNM staging system used for non-small cell lung cancer is also prognostic for SCLC and should be integrated into the classification scheme for patients with SCLC. The staging workup for SCLC has traditionally included contrast-enhanced CT scans of the chest and abdomen, bone scan, and MRI or CT scan of the brain. Recent data suggest that PET can improve both staging accuracy and treatment planning in patients with SCLC, although further prospective studies are needed to fully define its role.

Entities:  

Mesh:

Year:  2013        PMID: 23307985     DOI: 10.6004/jnccn.2013.0012

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  15 in total

1.  An orthotopic mouse model of small cell lung cancer reflects the clinical course in patients.

Authors:  Sanaz Taromi; Gian Kayser; Dominik von Elverfeldt; Wilfried Reichardt; Friederike Braun; Wolfgang A Weber; Robert Zeiser; Meike Burger
Journal:  Clin Exp Metastasis       Date:  2016-07-06       Impact factor: 5.150

2.  Evaluation of sarcopenia in small-cell lung cancer patients by routine chest CT.

Authors:  Eun Young Kim; Young Saing Kim; Inkeun Park; Hee Kyung Ahn; Eun Kyung Cho; Yu Mi Jeong; Jeong Ho Kim
Journal:  Support Care Cancer       Date:  2016-06-30       Impact factor: 3.603

3.  Development and validation of a novel diagnostic model for assessing lung cancer metastasis in a Chinese population based on multicenter real-world data.

Authors:  Yiyong Yao; Cunling Yan; Wei Zhang; San-Gang Wu; Jie Guan; Gang Zeng; Qiang Du; Chun Huang; Hui Zhang; Huiling Wang; Yanfeng Hou; Zhiyan Li; Lixin Wang; Yijie Zheng; Xun Li
Journal:  Cancer Manag Res       Date:  2019-10-29       Impact factor: 3.989

4.  The Relationship between Sarcopenia and Systemic Inflammatory Response for Cancer Cachexia in Small Cell Lung Cancer.

Authors:  Eun Young Kim; Young Saing Kim; Ja-Young Seo; Inkeun Park; Hee Kyung Ahn; Yu Mi Jeong; Jeong Ho Kim; Nambeom Kim
Journal:  PLoS One       Date:  2016-08-18       Impact factor: 3.240

5.  Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI.

Authors:  Eun Young Kim; Nambeom Kim; Young Saing Kim; Ja-Young Seo; Inkeun Park; Hee Kyung Ahn; Yu Mi Jeong; Jeong Ho Kim
Journal:  PLoS One       Date:  2016-10-05       Impact factor: 3.240

6.  Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancer.

Authors:  Sanaz Taromi; Florentine Lewens; Ruza Arsenic; Dagmar Sedding; Jörg Sänger; Almut Kunze; Markus Möbs; Joana Benecke; Helma Freitag; Friederike Christen; Daniel Kaemmerer; Amelie Lupp; Mareike Heilmann; Hedwig Lammert; Claus-Peter Schneider; Karen Richter; Michael Hummel; Britta Siegmund; Meike Burger; Franziska Briest; Patricia Grabowski
Journal:  Oncotarget       Date:  2017-09-23

7.  Triage of Limited Versus Extensive Disease on 18F-FDG PET/CT Scan in Small Cell lung Cancer.

Authors:  Riaz Saima; Bashir Humayun; Niazi Imran Khalid
Journal:  Asia Ocean J Nucl Med Biol       Date:  2017

Review 8.  Consolidative thoracic radiotherapy for extensive stage small cell lung cancer.

Authors:  Xiaoli Zhang; Jinming Yu; Hui Zhu; Xue Meng; Minghuan Li; Liyang Jiang; Xingchen Ding; Xindong Sun
Journal:  Oncotarget       Date:  2017-03-28

9.  Prognostic significance of CT-determined emphysema in patients with small cell lung cancer.

Authors:  Hee Young Lee; Eun Young Kim; Young Saing Kim; Hee Kyung Ahn; Yoon Kyung Kim
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

10.  Evaluation of factors associated with platinum-sensitivity status and survival in limited-stage small cell lung cancer patients treated with chemoradiotherapy.

Authors:  Qiang Wen; Xue Meng; Peng Xie; Shijiang Wang; Xindong Sun; Jinming Yu
Journal:  Oncotarget       Date:  2017-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.